Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of December 15, 2019
HIV vaccine trial uncovers plausible mechanisms of protection
From the HVTN, Vaccine and Infectious Disease Division
Cancer Research in 2019: Why we are counting on data science and tech to defeat cancer
Why we are counting on data science and tech to defeat cancer
‘Let the cells tell the story’
New tech is giving scientists unprecedented insights into single cells’ inner workings
Fred Hutch collaborates with new Allen Institute for Immunology
Multi-collaborator initiative aims to map the immune system in health and disease
Stronger and faster is not always better
From the Riddell, Paulovich Labs, Clinical Research Division and Gottardo Lab, Vaccine and Infectious Disease Division.
Want to make better T-cell therapies? First, figure out how they work.
New study maps out activities, effects of widely used components in cellular immunotherapies
3 new projects map out immune responses to cancers
Scientists aim to gather knowledge that improves future immunotherapies
Interrupting the Flow(Jo)
From the Gottardo Laboratory, Vaccine and Infectious Disease Division
Breaking tolerance: a story of two mechanisms and one disease
Gottardo Laboratory, Vaccine and Infectious Disease Division
Computational biologist Dr. Raphael Gottardo receives 2018 Mortimer Spiegelman Award
American Public Health Association recognizes Fred Hutch researcher for his contributions to health statistics biology
Dr. Raphael Gottardo awarded pilot funding from Chan Zuckerberg Initiative
The one-year project will adapt a statistical platform to support the Human Cell Atlas, a global cell-mapping research project
How does leukemia escape from immunotherapy?
New tech enables deep dive into mysterious results, sets stage for future improvements
Scientists-turned-entrepreneurs share lessons learned launching startups
From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found
mRNA: the future of vaccines?
The Gottardo Laboratory, Vaccine and Infectious Disease Division
Good News: Stemming the harm common virus causes in critically ill patients
Celebrating faculty and staff achievements
Will the flu vaccine work for you? Answer may be in your genes
Set of 9 genes that predicts flu response in adults under 35 could be first step to personalized vaccine
Targeting HIV vaccines to dendritic cells boosts the immune response
From the Vaccine and Infectious Disease Division
HIV vaccine: Could a few special cells help protect millions of people?
New analysis finds rare immune cells linked to HIV vaccine’s effectiveness